Can-Fite BioPharma Ltd.
CANF | AMEX
$2.22
-$0.02 (-0.89%)
At close: Sep 21, 2026, 4:00 PM ET
$2.26
+$0.04 (+1.74%)
Pre-market:
Sep 22, 2026, 6:16 AM ET
Fiscal Quarter Period Ending | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 | Q4 2020 Dec 30, 2020 | Q3 2020 Sep 29, 2020 | Q2 2020 Jun 29, 2020 | Q1 2020 Mar 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 6.45M | 6.45M | 4.83M | 4.83M | 4.72M | 4.72M | 4.28M | 3.38M | 3.46M | 1.26M | 2.98M | 3.73M | 1.71M | 5.5M | 4.39M | 5.81M | 1.03M | 2.74M | 8.27M | 10.22M | 9.06M | 5.77M |
Short-Term Investments | 2K | 2K | 3.06M | 3.06M | 9K | 9K | 4.64M | 4.56M | 6.16M | 11.15M | 5.01M | 7.09M | 11.05M | 11.2M | 14.75M | 7.86M | 6.78M | 8.87M | 75K | 57K | 78K | 46K |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -105K | -123K | -110K | -126K | -141K | -157K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.2M |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 47K | n/a | n/a | n/a | 48K | 811K | 1.75M | 1.02M | 18K | 2.96M | 3.57M | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -811K | -1.75M | -1.02M | n/a | -2.96M | -3.57M | n/a |
Other Current Assets | n/a | n/a | 1.1M | 77K | n/a | n/a | 78K | 1.12M | 1.29M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.73M |
Total Current Assets | 7.62M | 7.62M | 8.98M | 8.98M | 5.83M | 5.83M | 9.91M | 9.06M | 10.91M | 13.38M | 9.16M | 12.57M | 14.59M | 17.67M | 20.07M | 14.47M | 9.55M | 12.63M | 9.4M | 13.24M | 12.7M | 8.54M |
Property-Plant & Equipment | 96K | 96K | 138K | 138K | 94K | 94K | 81K | 105K | 123K | 110K | 126K | 141K | 157K | 174K | 185K | 165K | 127K | 117K | 123K | 86K | 96K | 107K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 96K | 96K | 138K | 138K | 94K | 94K | 81K | 105K | 123K | 110K | 126K | 141K | 157K | 174K | 185K | 165K | 127K | 117K | 123K | 86K | 96K | 1.31M |
Total Assets | 7.72M | 7.72M | 9.12M | 9.12M | 5.92M | 5.92M | 9.99M | 9.17M | 11.03M | 13.49M | 9.28M | 12.71M | 14.75M | 17.85M | 20.25M | 14.64M | 9.68M | 12.74M | 9.52M | 13.33M | 12.8M | 9.85M |
Account Payables | 1.15M | 1.15M | 618K | 618K | 885K | 885K | 427K | 647K | 810K | 963K | 896K | 1.47M | 824K | 1.12M | 954K | 806K | 1.01M | 290K | 561K | 784K | 437K | 5.04M |
Deferred Revenue | 405K | n/a | 405K | n/a | 636K | n/a | 622K | 783K | 783K | 783K | 783K | 818K | 818K | 818K | 818K | 1M | 1M | 1M | 334K | 603K | 556K | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | n/a | 405K | 675K | 405K | n/a | 636K | 694K | n/a | n/a | n/a | 492K | n/a | n/a | n/a | 603K | n/a | n/a | n/a | 96K | n/a | n/a | 1.05M |
Total Current Liabilities | 2.12M | 2.12M | 2.05M | 2.05M | 1.99M | 1.99M | 2.02M | 2.21M | 2.23M | 2.89M | 2.5M | 2.8M | 2.15M | 2.9M | 2.73M | 2.15M | 2.36M | 2.06M | 1.27M | 1.82M | 1.5M | 2.47M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 29K |
Other Long-Term Liabilities | n/a | 1.38M | n/a | 1.58M | n/a | 1.44M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.28M |
Total Long-Term Liabilities | 1.42M | 1.42M | 1.63M | 1.63M | 1.46M | 1.46M | 1.73M | 1.72M | 1.93M | 2.11M | 2.31M | 2.48M | 2.7M | 2.92M | 3.14M | 3.15M | 3.37M | 3.61M | 2.18M | 1.97M | 2.14M | 2.31M |
Total Liabilities | 3.54M | 3.54M | 3.68M | 3.68M | 3.44M | 3.44M | 3.75M | 3.93M | 4.16M | 5M | 4.81M | 5.28M | 4.85M | 5.82M | 5.87M | 5.31M | 5.73M | 5.66M | 3.45M | 3.79M | 3.64M | 4.78M |
Total Debt | 90K | 90K | 104K | 104K | 57K | 57K | 40K | 51K | 66K | 48K | 62K | 74K | 87K | 109K | 124K | 102K | 68K | 55K | 67K | 49K | 58K | 29K |
Book Value | 4.18M | 4.18M | 5.44M | 5.44M | 2.48M | 2.48M | 6.24M | 5.24M | 6.87M | 8.49M | 4.47M | 7.43M | 9.89M | 12.02M | 14.38M | 9.33M | 3.96M | 7.08M | 6.07M | 9.54M | 9.16M | 5.07M |
Book Value Per Share | 0.37 | 0.37 | 0.64 | 0.64 | 0.41 | 0.41 | 1.26 | 1.28 | 1.68 | 2.16 | 1.64 | 2.73 | 3.64 | 4.42 | 6.49 | 5.11 | 2.30 | 4.39 | 3.93 | 6.22 | 8.91 | 7.55 |
Common Stock | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 60.65M | 60.65M | 60.65M | 60.65M | 43.72M | 37.01M | 37.01M | 33.04M | 32.94M | 29.23M | 18.56M |
Retained Earnings | -171.24M | -171.24M | -166.36M | -166.36M | -162.44M | -162.44M | -158.48M | -156.83M | -155.07M | -153.4M | -150.85M | -147.83M | -145.3M | -143.11M | -140.67M | -133.97M | -130.57M | -127.35M | -125.47M | -121.84M | -119.26M | -115.37M |
Comprehensive Income | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M | 1.13M |
Shareholders Equity | 4.18M | 4.18M | 5.44M | 5.44M | 2.48M | 2.48M | 6.24M | 5.24M | 6.87M | 8.49M | 4.47M | 7.43M | 9.89M | 12.02M | 14.38M | 9.33M | 3.96M | 7.08M | 6.07M | 9.54M | 9.16M | 5.07M |
Total Investments | 2K | 2K | 3.06M | 3.06M | 9K | 9K | 4.64M | 4.56M | 6.16M | 11.15M | 5.01M | 7.09M | 11.05M | 11.2M | 14.75M | 7.86M | 6.78M | 8.87M | 75K | 57K | 78K | 46K |
Add to Watchlist
Select watchlists to add or remove CANF